INOVIO Pharmaceuticals initiates phase one human clinical trial for COVID-19 vaccine

BIO CEO Investor Presentation February 2021Подробнее

Inovio PharmaceuticalsПодробнее

How a Covid-19 Vaccine Human Trial WorksПодробнее

Inovio Pharmaceuticals Aims To Have More Than 1 Million COVID19 Vaccines By End Of YearПодробнее

Inovio Pharmaceuticals CEO on virus vaccine human trials, completing volunteer enrollment in AprilПодробнее

INO-4800 vaccine starts clinical trials in S. Korea -- WHO expert explains how it worksПодробнее

INOVIO begins phase 1 clinical trial for vaccineПодробнее

Coronavirus: Inovio Pharmaceuticals CEO talks conducting vaccine trialsПодробнее

Inovio's COVID-19 Vaccine Set To Go Through Critical Stage Three TrialПодробнее

Inovio’s COVID19 VaccineПодробнее

Woman Talks About Participating In OVID-19 Vaccine TrialПодробнее

Second vaccine trial for COVID-19 begins in the USПодробнее

Covid-19 vaccine: Inovio shows promise in preliminary clinical trialsПодробнее

Promising results for InovioПодробнее

Covid-19 Vaccine Could Be Available This Year, Inovio Co-Founder SaysПодробнее

Kate Broderick: INO-4800 – A DNA based vaccine against COVID-19Подробнее

In-Depth: Inovio COVID-19 vaccine's futureПодробнее

Coronavirus in Context: Participating in a COVID-19 Vaccine Clinical Trial | WebMDПодробнее

INOVIO's Phase 2 clinical trial underwayПодробнее

Inovio PharmaceuticalsПодробнее